Wataru Obuchi

632 total citations
15 papers, 487 citations indexed

About

Wataru Obuchi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wataru Obuchi has authored 15 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Wataru Obuchi's work include Extracellular vesicles in disease (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). Wataru Obuchi is often cited by papers focused on Extracellular vesicles in disease (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and RNA Interference and Gene Delivery (3 papers). Wataru Obuchi collaborates with scholars based in Japan, United States and Germany. Wataru Obuchi's co-authors include Sumio Ohtsuki, Tetsuya Terasaki, Yasuo Uchida, Masanori Tachikawa, Yutaro Hoshi, Kenji Nakamura, Takuya Kuno, Mio Hirayama‐Kurogi, Toshihiro Yoneyama and Shingo Ito and has published in prestigious journals such as PLoS ONE, Cancer Research and Molecular Pharmacology.

In The Last Decade

Wataru Obuchi

14 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wataru Obuchi Japan 8 211 209 80 78 78 15 487
Denggao Yao United Kingdom 15 238 1.1× 236 1.1× 82 1.0× 164 2.1× 9 0.1× 25 685
Seng Chuan Tang Netherlands 12 380 1.8× 244 1.2× 89 1.1× 48 0.6× 5 0.1× 15 582
Takashi Tsuruo Japan 8 349 1.7× 264 1.3× 165 2.1× 38 0.5× 5 0.1× 10 594
Tomáš Eckschlager Czechia 10 84 0.4× 165 0.8× 17 0.2× 20 0.3× 27 0.3× 21 432
Xijun Liu China 15 136 0.6× 340 1.6× 9 0.1× 41 0.5× 12 0.2× 27 629
Alan C. Gough United Kingdom 11 159 0.8× 333 1.6× 39 0.5× 316 4.1× 12 0.2× 12 645
Adrian Stecuła United States 10 129 0.6× 163 0.8× 48 0.6× 43 0.6× 9 0.1× 10 407
Kristine Hole Norway 12 511 2.4× 537 2.6× 28 0.3× 79 1.0× 19 0.2× 26 756
Felix Kartnig Austria 11 157 0.7× 405 1.9× 17 0.2× 8 0.1× 15 0.2× 21 615
Ming-Bai Hu China 14 109 0.5× 177 0.8× 9 0.1× 30 0.4× 14 0.2× 19 435

Countries citing papers authored by Wataru Obuchi

Since Specialization
Citations

This map shows the geographic impact of Wataru Obuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wataru Obuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wataru Obuchi more than expected).

Fields of papers citing papers by Wataru Obuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wataru Obuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wataru Obuchi. The network helps show where Wataru Obuchi may publish in the future.

Co-authorship network of co-authors of Wataru Obuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Wataru Obuchi. A scholar is included among the top collaborators of Wataru Obuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wataru Obuchi. Wataru Obuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Takahashi, Keiko, Yoshinobu Shiose, M Yamada, et al.. (2025). DS-3939a: A TA-MUC1–Directed Antibody–Drug Conjugate with Broad Antitumor Activity. Molecular Cancer Therapeutics. 25(1). 7–20. 1 indexed citations
2.
Obuchi, Wataru, Kevin Leandro, David Rufino‐Ramos, et al.. (2025). Engineering of CD63 Enables Selective Extracellular Vesicle Cargo Loading and Enhanced Payload Delivery. Journal of Extracellular Vesicles. 14(6). e70094–e70094. 5 indexed citations
3.
Ianni, Emilio Di, Wataru Obuchi, Koen Breyne, & Xandra O. Breakefield. (2025). Extracellular vesicles for the delivery of gene therapy. Nature Reviews Bioengineering. 3(5). 360–373. 13 indexed citations
4.
Nakazawa, Yusuke, Hiroyuki Okada, Yasuhito Nagamoto, et al.. (2024). Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity. Bioorganic & Medicinal Chemistry. 111. 117862–117862. 1 indexed citations
5.
Takahashi, Kazuki, Yoshinobu Shiose, Wataru Obuchi, et al.. (2024). Abstract 6579: DS-3939a, a novel TA-MUC1-targeting antibody-drug conjugate (ADC) with a DNA topoisomerase I inhibitor DXd, exhibits potent antitumor activity in preclinical models. Cancer Research. 84(6_Supplement). 6579–6579. 1 indexed citations
6.
Goto, Megumi, Kentaro Ito, Tomohiro Watanabe, et al.. (2023). Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models. European Journal of Pharmacology. 961. 176184–176184. 10 indexed citations
7.
Vaine, Christine A., Wataru Obuchi, Shadi Mahjoum, et al.. (2023). Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkers. Molecular Therapy. 31(7). 2206–2219. 5 indexed citations
8.
Ichida, Hiroyuki, Tatsuki Fukami, Kenji Mishiro, et al.. (2022). Quantitative Evaluation of the Contribution of Each Aldo-Keto Reductase and Short-Chain Dehydrogenase/Reductase Isoform to Reduction Reactions of Compounds Containing a Ketone Group in the Human Liver. Drug Metabolism and Disposition. 51(1). 17–28. 8 indexed citations
9.
Koizumi, Makoto, et al.. (2021). RNA interference activity of single-stranded oligonucleotides linked between the passenger strand and the guide strand with an aryl phosphate linker. Nucleosides Nucleotides & Nucleic Acids. 40(6). 647–664. 1 indexed citations
10.
Koizumi, Makoto, Yasuhide Hirota, Masakazu Tamura, et al.. (2019). Design of 2'-O-methyl RNA and DNA double-stranded oligonucleotides: naturally-occurring nucleotide components with strong RNA interference gene expression inhibitory activity. Nucleosides Nucleotides & Nucleic Acids. 39(1-3). 292–309. 3 indexed citations
11.
Furuta, Takuya, Sumio Ohtsuki, Masanori Tachikawa, et al.. (2018). Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics. PLoS ONE. 13(3). e0193799–e0193799. 87 indexed citations
12.
13.
Ohtsuki, Sumio, Hirotaka Kawakami, Tae Inoue, et al.. (2014). Validation of uPA/SCID Mouse with Humanized Liver as a Human Liver Model: Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases by LC-MS/MS. Drug Metabolism and Disposition. 42(6). 1039–1043. 37 indexed citations
14.
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denggao Yao Breakdown of academic impact, for papers by Seng Chuan Tang Breakdown of academic impact, for papers by Takashi Tsuruo Breakdown of academic impact, for papers by Tomáš Eckschlager Breakdown of academic impact, for papers by Xijun Liu Breakdown of academic impact, for papers by Alan C. Gough Breakdown of academic impact, for papers by Adrian Stecuła Breakdown of academic impact, for papers by Kristine Hole Breakdown of academic impact, for papers by Felix Kartnig Breakdown of academic impact, for papers by Ming-Bai Hu
Rankless by CCL
2026